(2R,3S,5S)-5-(4-amino-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol(CAS: 60129-59-1)

This compound (CAS: 60129-59-1) falls under the scope of regulatory guidelines such as REACH in Europe, ensuring that manufacturers and importers register the substance and manage any potential risks. In the USA, it must comply with FDA regulations for pharmaceuticals and EPA guidelines for environmental protection. Additionally, it should adhere to GHS classification standards, including labeling and safety data sheets.

Alternatives to this compound include other pyrimidine-based analogs such as 5-(4-amino-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-2-hydroxymethyltetrahydrofuran-3-ol derivatives. Isomers like (2S,3R,5S)- and (2S,3S,5R)-isomers can also be used, and common alternative reagents in synthesis might include 2,3-dihydrofuran-2-carbaldehyde and 4-amino-7H-pyrrolo[2,3-d]pyrimidine-7-carbaldehyde.

The market trend for this compound is driven by its applications in drug discovery and synthesis, particularly in the development of antiviral and anticancer drugs. Research is focusing on optimizing its synthesis and improving its bioavailability. The trend shows a growing demand for this compound in the pharmaceutical industry, with ongoing studies exploring its potential therapeutic benefits.

Waste containing this compound should be collected in appropriate, labeled containers and stored under controlled conditions to prevent degradation. It should then be disposed of through professional waste disposal services that comply with local environmental regulations. Incineration is a common method for disposal, ensuring complete destruction of the compound. Additionally, proper environmental precautions should be taken to minimize any potential environmental impact.